Peering Into IREN's Recent Short Interest - IREN ( NASDAQ:IREN )
IREN's IREN short percent of float has risen 5.87% since its last report. The company recently reported that it has 22.25 million shares sold short, which is 10.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.34 days to cover their ...
XRP Allocations More Common Than Solana Among Institutions: Coinbase, EY
Asset managers have filed applications for exchange-traded funds tracking both assets as interest in altcoins has risen.
PearlX Brings Solar Amenities to Apartment Residents at New Sand Canyon Community
LOS ANGELES, March 18, 2025 ( GLOBE NEWSWIRE ) -- PearlX, an energy infrastructure and capital partner to multifamily owners and developers, has committed to invest $3 million to bring a solar power and battery system to Sand Canyon, a new, 323-unit, 582-bedroom apartment community under ...
Toll Brothers Announces New Phase of Homes Coming Soon to Toll Brothers at Jordanelle Ridge Community in Heber City, Utah
HEBER CITY, Utah, March 18, 2025 ( GLOBE NEWSWIRE ) -- Toll Brothers, Inc. ( NYSE:TOL ) , the nation's leading builder of luxury homes, has announced a new phase of future home sites in its Toll Brothers at Jordanelle Ridge community in Heber City, Utah.
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Innovative Industrial Properties - Innovative Ind Props ( NYSE:IIPR )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Innovative Industrial Properties To Contact Him Directly To Discuss Their Options
Toll Brothers Announces New Phase of Homes Coming Soon to Toll Brothers at Jordanelle Ridge Community in Heber City, Utah - Toll Brothers ( NYSE:TOL )
HEBER CITY, Utah, March 18, 2025 ( GLOBE NEWSWIRE ) -- Toll Brothers, Inc. TOL, the nation's leading builder of luxury homes, has announced a new phase of future home sites in its Toll Brothers at Jordanelle Ridge community in Heber City, Utah.
Immunovant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis ( MG ) and Chronic Inflammatory Demyelinating Polyneuropathy ( CIDP ) Programs - Immunovant ( NASDAQ:IMVT )
NEW YORK, March 18, 2025 ( GLOBE NEWSWIRE ) -- Immunovant, Inc. IMVT, a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced that it will host an investor webcast on Wednesday, March 19th at 8:00 a.m.
Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis ( MG ) and Chronic Inflammatory Demyelinating Polyneuropathy ( CIDP ) Programs
NEW YORK, March 18, 2025 ( GLOBE NEWSWIRE ) -- Immunovant, Inc. ( Nasdaq: IMVT ) , a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced that it will host an investor webcast on Wednesday, March 19th at 8:00 a.m.
Immunovant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis ( MG ) and Chronic Inflammatory Demyelinating Polyneuropathy ( CIDP ) Programs
NEW YORK, March 18, 2025 ( GLOBE NEWSWIRE ) -- Immunovant, Inc. ( Nasdaq: IMVT ) , a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced that it will host an investor webcast on Wednesday, March 19th at 8:00 a.m.
Roivant to Host Investor Webcast at 8:00 AM ET on Wednesday, March 19 to Review Results from Batoclimab Myasthenia Gravis ( MG ) and Chronic Inflammatory Demyelinating Polyneuropathy ( CIDP ) Programs - Immunovant ( NASDAQ:IMVT ) , Roivant Sciences ( NASDAQ:ROIV )
NEW YORK, March 18, 2025 ( GLOBE NEWSWIRE ) -- Immunovant, Inc. IMVT, a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today announced that it will host an investor webcast on Wednesday, March 19th at 8:00 a.m.